17 alpha-hydroxyprogesterone caproate has been researched along with norethindrone enanthate in 1 studies
| Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (norethindrone enanthate) | Trials (norethindrone enanthate) | Recent Studies (post-2010) (norethindrone enanthate) |
|---|---|---|---|---|---|
| 517 | 88 | 251 | 188 | 49 | 34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giwa-Osagie, OF | 1 |
1 review(s) available for 17 alpha-hydroxyprogesterone caproate and norethindrone enanthate
| Article | Year |
|---|---|
Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Carbohydrate Metabolism; Contraceptive Agents, Female; Estradiol; Female; Hemostasis; Humans; Hydroxyprogesterones; Injections; Lipid Metabolism; Medroxyprogesterone Acetate; Norethindrone | 1994 |